Table 2.

Postoperative data.

	Group A	Group B	Group C
Follow-up, mo	20.8 ± 4.2	18.9 ± 5.3	19.2 ± 5.5
IOP, mmHg	17.5 ± 6.1	15.6 ± 7.2	16.3 ± 4.9
BCVA	0.05–0.6	NLP-0.5	FC-0.5
Glaucoma medications	0.6 ± 0.4	0.5 ± 0.5	0.5 ± 0.4
Graft thinner (eyes)	19 (18%)	6 (5%)	3 (2.7%)
Tube exposure (eyes)	3 (3%)	1 (0.8%)	0 (0%)
Plate exposure (eyes)	0 (0%)	0 (0%)	0 (0%)
Repair surgery (eyes)	2 (1.9%)	1 (0.8%)	0 (0%)